76 results
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
patients with Opportunistic ... Infections • Pulmonary ... count <50 • Pulmonary ... Antiretroviral #Therapy ... #Infections #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
• CNS opportunistic ... antiretroviral therapy ... antiretroviral therapy ... antimicrobial therapy ... antiretroviral therapy
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... disease (COPD) is ... escalation in therapy ... Treatment #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
illness usually is ... /ml Preferred Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
areas Preferred Therapy ... Patients Preferred Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Chronic Maintenance Therapy ... mm3 Preferred Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
days) Preferred Therapy ... or Alternative Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Cross-Reactivity of Penicillins and Cephalosporins

Cross reactivity of penicillin-allergic patients to cephalosporins has more to do with
cross-reactivity is ... <1%, and there is ... Cephalosporins #Allergy #Management ... Reaction #Incidence #PCN ... #Pharmacology